Drug manufacturers and partners look toward advancements in post-COVID world
With a global pandemic barely in the rearview mirror, the gaze of the pharmaceutical industry is clearly focused on what lies ahead.
The tough lessons taught by COVID-19 have reshaped the global pharmaceutical supply chain and how manufacturers approach bringing new treatments to market. Pharma has also placed emphasis on coordination and communication with downstream stakeholders like distributors, payors, physicians, pharmacies and the ultimate end user—the patient.
For the full article, please visit FiercePharma.